Skip to main content
. 2013 Jun 1;53(1):68–72. doi: 10.3164/jcbn.13-14

Fig. 2.

Fig. 2

Effect of subcutaneous liraglutide on plasma concentrations of (a) glucose, (b) insulin, (c) C-peptide, (d) glucagon, and (e) incremental ratio of plasma glucagon (%Basal) after the test meals (n = 14). %Basal = 100 × postprandial plasma glucagon (15–180 min)/baseline plasma glucagon (0 min).